The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
At the conclusion of this activity, learners should be able to: Review addiction identification and evidence-based treatments. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients. Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient. Explain the process of buprenorphine induction as well as stabilization and maintenance. Discuss other approved antagonist and agonist medications to treat OUD. Discuss basic office protocols including medical record documentation and confidentially. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD. Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.
Webinar Description: Language matters when it comes to treating substance use disorders (SUD). Stigma has been proven to have a negative impact on health outcomes, not only leading many individuals with SUD to not seek treatment, but also influencing how health professionals treat their patients. Using non-stigmatizing, person-centered, and recovery-oriented language can help providers facilitate engagement in treatment for individuals with SUD. This webinar will explore the ever-evolving landscape of language around SUD and discuss strategies for healthcare providers and allied health professionals to address stigma within your practice.
PCSS-MAT is comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder, including courses satisfying the DATA-2000 waiver.
The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.Learn More